Epstein Secrets

a nation of its size and wealth. Healthcare Expenditure / GDP To": OECD Average USA 9.3 17.2 UK 9.4 Sweden 9.5 Spain 9.3 Portugal 10.2 Norway 9.3 Netherlands 11.9 Japan 9.6 Italy 9.2 Germany 11.3 France 11.6 Finland 9.0 Canada 11.2 Belgium 10.5 Australia 8.9 Healthcare e

led investments in various life- science/IT/healthcare companies such as Foundation Medicine and Research Gate, served on the board of directors of Schrodinger, and monitored Nimbus. On the not-for-profit side, Dr. Nikolic co- managed BMGF's $1.5 billion strategic-investment pool, focused on program-related

ation in society, but would leave ample time for family, friendship and leisure. To many the above will seem ridiculously naïve, but the example of Norway given previously shows that the numbers can add up, and a three day week is feasible. As long as enough capital is available. Futurologists' predi

intuitively wrong. In most of the things that humans count, more is better, while with entropy less is normally better. In later sections I follow Schrodinger in using the concept of 'negentropy' (negative-entropy) to get round this problem. The important point of the energy/information debate is that the

be used directly, or with storage for use at night. Current storage options include hydroelectric, already used in Northern Europe with storage in Norway, hot oil in CSP plants, grid scale sodium/sulphur batteries, or just old fashioned domestic electrical storage heaters with bricks in them. The cos

the question of what is negentropy. Erwin Schr0dinger first introduced the concept of negentropy, in his 1944 popular-science book 'What is life?' [Schrodinger 1944] and it was used in the discussion of living systems. Schrodinger explained his use of this phrase: if I had been catering for them [physicist

jurisdiction in which, or to any person to whom, it would not be lawful to make the offer or invitation. STRICTLY CONFIDENTIAL 75 EFTA00586931 Norway Notice to Investors In Norway This Memorandum does not constitute an invitation or a public offer of securities in the Kingdom of Norway. It is in

activities. On the for-profit side, Boris led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus through Bill Gates Ventures. On the non-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on progr